CHARACTERIZATION OF CELLULAR DEFECTS OF INSULIN ACTION IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS

CHARACTERIZATION OF CELLULAR DEFECTS OF INSULIN ACTION IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS
复制标题

DOI:
10.1172/jci116226
复制
发表时间:
1993-02-01
影响因子:
15.9
通讯作者:
DEFRONZO, RA
DEFRONZO, RA
中科院分区:
医学1区
文献类型:
--
作者:
DELPRATO, S;BONADONNA, RC;DEFRONZO, RA

文献摘要

被引文献

相似文献

7名非胰岛素依赖型糖尿病(NIDDM)患者参加了3项钳夹试验,分别使用[3-H-3]和[U-C-14]葡萄糖和间接量热法:研究I,正常血糖(5.2+/-0.1 mM)胰岛素(269+/-39 pM)钳夹;研究II,高血糖(14.9+/-1.2 mM)胰岛素(259+/-19 pM)钳夹;研究III,正常血糖(5.5+/-0.3 mM)高胰岛素血症(1650+/-529 pM)钳夹。7名对照受试者接受正常血糖(5.1+/-0.2 mM)胰岛素(258+/-24 pM)钳夹。糖酵解和葡萄糖氧化从(H2O)-H-3和(CO2)-C-14的出现率进行定量;糖原合成计算为身体葡萄糖处置和糖酵解之间的差异。在研究I中,与对照组相比,NIDDM患者的葡萄糖摄取减少了54%。NIDDM患者糖酵解、糖原合成和葡萄糖氧化减少(P < 0.05-0.001)。非氧化性糖酵解和脂质氧化较高。在研究II和III中,NIDDM的葡萄糖摄取与对照组相同(40.7+/-2.1和40.7+/-1.7 mumol/min)。kg去脂质量)。在研究II中,糖酵解,而不是葡萄糖氧化,是正常的(P < 0.01与对照组)。非氧化糖酵解仍高于对照组(P < 0.05)。糖原沉积增加(与研究I相比P < 0.05),脂质氧化保持较高水平(P < 0.01)。在研究III中,高胰岛素血症使糖原形成、糖酵解和脂质氧化正常化,但未使非氧化糖酵解升高或葡萄糖氧化降低正常化。脂质氧化与糖酵解呈负相关(r = -0.65; P < 0.01),葡萄糖氧化呈负相关(r = -0.75; P < 0.01)。总之,在NIDDM:(a)胰岛素抵抗涉及糖酵解、糖原合成和葡萄糖氧化;(B)高血糖症和高胰岛素血症可使全身葡萄糖摄取正常化;(c)显著的高胰岛素血症使糖原合成和通过糖酵解的总流量正常化,但不能恢复氧化和非氧化糖酵解之间的正常分布;(d)高血糖症不能克服葡萄糖氧化和非氧化糖酵解中的缺陷;(e)脂质氧化升高,并且仅在高胰岛素血症时受到抑制。
Seven non-insulin-dependent diabetes mellitus (NIDDM) patients participated in three clamp studies performed with [3-H-3]and [U-C-14]glucose and indirect calorimetry: study I, euglycemic (5.2+/-0.1 mM) insulin (269+/-39 pM) clamp; study II, hyperglycemic (14.9+/-1.2 mM) insulin (259+/-19 pM) clamp; study III, euglycemic (5.5+/-0.3 mM) hyperinsulinemic (1650+/-529 pM) clamp. Seven control subjects received a euglycemic (5.1+/-0.2 mM) insulin (258+/-24 pM) clamp. Glycolysis and glucose oxidation were quantitated from the rate of appearance of (H2O)-H-3 and (CO2)-C-14; glycogen synthesis was calculated as the difference between body glucose disposal and glycolysis. In study I, glucose uptake was decreased by 54% in NIDDM vs. controls. Glycolysis, glycogen synthesis, and glucose oxidation were reduced in NIDDM patients (P < 0.05-0.001). Nonoxidative glycolysis and lipid oxidation were higher. In studies II and III, glucose uptake in NIDDM was equal to controls (40.7+/-2.1 and 40.7+/-1.7 mumol/min . kg fat-free mass, respectively). In study II, glycolysis, but not glucose oxidation, was normal (P < 0.01 vs. controls). Nonoxidative glycolysis remained higher (P < 0.05). Glycogen deposition increased (P < 0.05 vs. study I), and lipid oxidation remained higher (P < 0.01). In study III, hyperinsulinemia normalized glycogen formation, glycolysis, and lipid oxidation but did not normalize the elevated nonoxidative glycolysis or the decreased glucose oxidation. Lipid oxidation and glycolysis (r = -0.65; P < 0.01), and glucose oxidation (r = -0.75; P < 0.01) were inversely correlated. In conclusion, in NIDDM: (a) insulin resistance involves glycolysis, glycogen synthesis, and glucose oxidation; (b) hyperglycemia and hyperinsulinemia can normalize total body glucose uptake; (c) marked hyperinsulinemia normalizes glycogen synthesis and total flux through glycolysis, but does not restore a normal distribution between oxidation and nonoxidative glycolysis; (d) hyperglycemia cannot overcome the defects in glucose oxidation and nonoxidative glycolysis; (e) lipid oxidation is elevated and is suppressed only with hyperinsulinemia.